Account
Inquiry
XCE tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
As a research chemical, XCE tirzepatide exhibits greater affinity for GIP receptors than GLP-1 receptors. This unique dual agonist behavior has shown significant potential in reducing hyperglycemia in preclinical studies. The compound mimics the actions of natural GIP at the GIP receptor while maintaining GLP-1 receptor activity.
Our XCE tirzepatide is supplied as a white powder with pharmaceutical grade purity (>99%). The product is carefully packaged to ensure stability during transportation and storage. Each batch undergoes rigorous quality control testing to guarantee consistent performance in research applications.
For research purposes only. Not for human consumption. This product is intended solely for laboratory research by qualified professionals in controlled settings.
